INDP: the cash flow

MyFinsight

For the year ending 2025-12-31, INDP had $2,720,875 increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Total research and development	9,340,959
General and administrative	10,492,554
Other income, net	138,018
Change in fair value of convertible promissory notes	-1,153,421
Net loss	-20,848,916
Stock-based compensation	1,358,082
Change in fair value of convertible promissory notes	-1,153,421
Prepaid expenses and other current and non- current assets	-667,288
Accounts payable and other current liabilities	2,848,858
Operating lease right-of-use asset and liability, net	-1,989
Net cash used in operating activities	-14,823,256
Proceeds from issuance of convertible promissory notes	5,714,800
Proceeds from issuance of shares of common stock and warrants	6,396,888
Proceeds from issuance of preferred stock	6,000,000
Proceeds from exercise of pre-funded warrants	1,908
Issuance costs	569,465
Net cash provided by financing activities	17,544,131
Net increase (decrease) in cash and cash equivalents	2,720,875
Cash and cash equivalents at beginning of period	5,786,753
Cash and cash equivalents at end of period	8,507,628

Unit: Dollar.